Clinical application of the AUC-guided dosage adjustment of docetaxel-based chemotherapy for patients with solid tumours: a single centre, prospective and randomised control study
Ning Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Yan Zhang(Wuhan University), Jianwei Lu(Nantong Tumor Hospital), Xiaomei Zhang(The University of Texas MD Anderson Cancer Center), Bo Shen(Jiangsu Cancer Hospital), Deliang Yang(Xuzhou Central Hospital), Geyu Liang(Southeast University), Huayun Zhu(Jiangsu Cancer Hospital), Jiali Zhu(Jiangsu Province Hospital)
Cited by 12
Related Papers
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
|Nature|2017|853
Extracellular Histones Are Mediators of Death through TLR2 and TLR4 in Mouse Fatal Liver Injury
|The Journal of Immunology|2011|522
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
|Cancer Research|2013|485
Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state
|Science Translational Medicine|2019|316